BCM
ASMB icon

Bridgeway Capital Management’s Assembly Biosciences ASMB Stock Holding History

Bridgeway Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,225
Closed -$390K – 1225
2025
Q3 		$390K Hold
15,225
– – 0.01% 853
2025
Q2 		$276K Hold
15,225
– – 0.01% 884
2025
Q1 		$146K Buy
15,225
+1,200
+9% +$15.7K ﹤0.01% 982
2024
Q4 		$221K Sell
14,025
-475
-3% -$7.65K 0.01% 982
2024
Q3 		$220K Hold
14,500
– – ﹤0.01% 1042
2024
Q2 		$199K Hold
14,500
– – ﹤0.01% 1063
2024
Q1 		$193K Hold
14,500
– – ﹤0.01% 1114
2023
Q4 		$143K Hold
14,500
– – ﹤0.01% 1192
2023
Q3 		$154K Hold
14,500
– – ﹤0.01% 1143
2023
Q2 		$200K Hold
14,500
– – ﹤0.01% 1138
2023
Q1 		$146K Sell
14,500
-1,183
-8% -$20K ﹤0.01% 1164
2022
Q4 		$245K Hold
15,683
– – 0.01% 1034
2022
Q3 		$309K Buy
15,683
+1,183
+8% +$28.6K 0.01% 1028
2022
Q2 		$365K Hold
14,500
– – 0.01% 947
2022
Q1 		$358K Buy
14,500
+12,308
+561% +$264K 0.01% 1025
2021
Q4 		$61K Hold
2,192
– – ﹤0.01% 1238
2021
Q3 		$92K Sell
2,192
-3,141
-59% -$132K ﹤0.01% 1255
2021
Q2 		$248K Sell
5,333
-7,167
-57% -$355K ﹤0.01% 1235
2021
Q1 		$690K Buy
+12,500
New +$828K 0.01% 1000

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Bridgeway Capital Management's ASMB Position: Q4 2025 in Review

Bridgeway Capital Management sold out of Assembly Biosciences (ASMB) in Q4 2025, closing a stake of 15,225 shares — an estimated $390K sold.

Bridgeway Capital Management first reported a position in ASMB in Q1 2021 and held it in 19 quarters. The position peaked at $690K in Q1 2021. 69 funds tracked by Wall St. Rank hold ASMB as of Q4 2025.

  • Bridgeway Capital Management reported no remaining Assembly Biosciences position as of Q4 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 15,225 Assembly Biosciences shares in Q4 2025, an estimated $390K.
  • Bridgeway Capital Management first reported a position in Assembly Biosciences in Q1 2021 and held it in 19 quarters.
  • Bridgeway Capital Management's Assembly Biosciences position peaked at $690K in Q1 2021.
  • 69 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2025.

Based on Bridgeway Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.